COPP regimen
|
WikiDoc Resources for COPP regimen |
|
Articles |
|---|
|
Most recent articles on COPP regimen Most cited articles on COPP regimen |
|
Media |
|
Powerpoint slides on COPP regimen |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on COPP regimen at Clinical Trials.gov Clinical Trials on COPP regimen at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on COPP regimen
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on COPP regimen Discussion groups on COPP regimen Patient Handouts on COPP regimen Directions to Hospitals Treating COPP regimen Risk calculators and risk factors for COPP regimen
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for COPP regimen |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords:COPP; COPP Regimen; COPP regimen; CTX/PCB/PRED/VCR; Cyclophosphamide/Prednisone/Procarbazine/Vincristine; Cytoxan-Oncovin-Procarbazine-Prednisone Regimen
Overview
COPP regimen refers to a derivative of the original MOPP regimen consisting of cyclophosphamide, vincristine, procarbazine and prednisone used as an initial treatment for Hodgkin's lymphoma. Also used for the treatment of non-Hodgkin's lymphoma.[1]
Regimen
CCyclophosphamide
VVincristine (oncovin)
PProcarbazine
PPrednisone